Skip to main content
Premium Trial:

Request an Annual Quote

Stephen Worsley

Indi Molecular has named Stephen Worsley its senior VP of business development. Worsley joins the firm from Peregrine Pharmaceuticals, where he served as VP of business development. Earlier, he held the post of chief business officer at Centrose Pharmaceutical, and he was VP of business development for Intrexon, among other similar positions at a variety of biotech firms.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more